A Diagnostic Tool for Identification of Etiologies of Fever of Unknown Origin in Adult Patients

Abstract

The diagnosis and treatment of fever of unknown origin (FUO) are huge challenges to clinicians. Separating the etiologies of FUO into infectious and non-infectious disease is conducive to clinical physicians not only on making decisions rapidly concerning the prescription of suitable antibiotics but also on further analysis of the final diagnosis. In order to develop and validate a diagnostic tool to efficiently distinguish the etiologies of adult FUO patients as infectious or non-infectious disease, FUO patients from the departments of infectious disease and internal medicine in three Chinese tertiary hospitals were enrolled retrospectively and prospectively. By using polynomial logistic regression analysis, the diagnostic formula and the associated scoring system were developed. The variables included in this diagnostic formula were from clinical evaluations and common laboratory examinations. The proposed tool could discriminate infectious and non-infectious causes of FUO with an area under receiver operating characteristic curve (AUC) of 0.83, sensitivity of 0.80 and specificity of 0.75. This diagnosis tool could predict the infectious and non-infectious causes of FUO in the validation cohort with an AUC of 0.79, sensitivity of 0.79 and specificity of 0.70. The results suggested that this diagnostic tool could be a reliable tool to discriminate between infectious and non-infectious causes of FUO.

Keywords

fever of unknown origin / prediction model / diagnostic tool / etiology / empiric therapy

References

[1] VanderschuerenS, KnockaertD, AdriaenssensT, et al.. From prolonged febrile illness to fever of unknown origin: the challenge continues. Arch Intern Med, 2003, 163(9): 1033-1041

[2] HayakawaK, RamasamyB, ChandrasekarPH. Fever of unknown origin: an evidence-based review. Am J Med Sci, 2012, 344(4): 307-316

[3] HorowitzHW. Fever of unknown origin or fever of too many origins?. N Engl J Med, 2013, 368(3): 197-199

[4] Mulders-MandersC, SimonA, Bleeker-RoversC. Fever of unknown origin. Clin Med (Lond), 2015, 15(3): 280-284

[5] NaitoT, MizookaM, MitsumotoF, et al.. Diagnostic workup for fever of unknown origin: a multicenter collaborative retrospective study. BMJ Open, 2013, 3(12): e003971

[6] ErgonulO, WillkeA, AzapA, et al.. Revised definition of ‘fever of unknown origin’: limitations and opportunities. J Infect, 2005, 50(1): 1-5

[7] ShiXC, LiuXQ, ZhouBT, et al.. Major causes of fever of unknown origin at Peking Union Medical College Hospital in the past 26 years. Chin Med J (Engl), 2013, 126(5): 808-812

[8] TuJC, PingZ, LiXJ, et al.. Clinical Etiologies of Fever of Unknown Origin in 500 Cases. Zhongguo Yi Xue Ke Xue Yuan Xue Bao (Chinese), 2015, 37(3): 348-351

[9] NakamuraA, SugimotoY, OhishiK, et al.. Diagnostic value of PCR analysis of bacteria and fungi from blood in empiric-therapy-resistant febrile neutropenia. J Clin Microbiol, 2010, 48(6): 2030-2036

[10] YamanouchiM, UeharaY, YokokawaH, et al.. Analysis of 256 cases of classic fever of unknown origin. Intern Med, 2014, 53(21): 2471-2475

[11] HuelsenbeckJP, BullJJ, CunninghamCW. Combining data in phylogenetic analysis. Trends Ecol Evol, 1996, 11(4): 152-158

[12] MirT, Nabi DhobiG, Nabi KoulA, et al.. Clinical profile of classical Fever of unknown origin (FUO). Caspian J Intern Med, 2014, 5(1): 35-39

[13] CunhaBA, LortholaryO, CunhaCB. Fever of unknown origin: a clinical approach. Am J Med, 2015, 128(10): 1138.e1-1138.e15

[14] WangHY, YangCF, ChiouTJ, et al.. A “bone marrow score” for predicting hematological disease in immunocompetent patients with fevers of unknown origin. Medicine, 2014, 93(27): e243

[15] TokmakH, ErgonulO, DemirkolO, et al.. Diagnostic contribution of (18)F-FDG-PET/CT in fever of unknown origin. Int J Infect Dis, 2014, 19(2): 53-58

[16] ShengZK, YeJ, LiJJ, et al.. Utility of fluorodeoxyglucose positron emission tomography/computed tomography in patients with fever of unknown origin diagnosed as lymphoma. Med Princ Pract, 2014, 23(5): 437-442

[17] YangJ, LiuX, AiD, et al.. PET Index of Bone Glucose Metabolism (PIBGM) Classification of PET/CT Data for Fever of Unknown Origin Diagnosis. PLoS One, 2015, 10(6): e0130173

[18] HaoR, YuanL, KanY, et al.. Diagnostic performance of 18F-FDG PET/CT in patients with fever of unknown origin: a meta-analysis. Nucl Med Commun, 2013, 34(7): 682-688

[19] ChengH, YangL, XiongJ, et al.. Multiple thyroid nodules in the lung: metastasis or ectopia?. Diagn Pathol, 2015, 10(6): 1-6

[20] SuL, HanB, LiuC, et al.. Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study. BMC Infect Dis, 2012, 12(7): 157-166

[21] ManzanoS, BaileyB, GervaixA, et al.. Markers for bacterial infection in children with fever without source. Arch Dis Child, 2011, 96(5): 440-446

[22] CunhaBA, PherezFM, KatzDS. Fever of unknown origin (FUO) due to a solitary cavitary lung lesion: the deadly ferritin-laced doughnut. Heart Lung, 2010, 39(4): 340-344

[23] NijmanRG, VergouweY, ThompsonM, et al.. Clinical prediction model to aid emergency doctors managing febrile children at risk of serious bacterial infections: diagnostic study. BMJ, 2013, 346: f1706

[24] Van den BruelA, Haj-HassanT, ThompsonM, et al.. Diagnostic value of clinical features at presentation to identify serious infection in children in developed countries: a systematic review. Lancet, 2010, 375(9717): 834-845

[25] FaixJD. Biomarkers of sepsis. Crit Rev Clin Lab Sci, 2013, 50(1): 23-36

[26] RuanQ, ZhangS, AiJ, et al.. Screening of latent tuberculosis infection by interferon-gamma release assays in rheumatic patients: a systemic review and meta-analysis. Clin Rheumatol, 2016, 35(2): 417-425

[27] Si-TaharM, TouquiL, ChignardM. Innate immunity and inflammation—two facets of the same anti-infectious reaction. Clin Exp Immunol, 2009, 156(2): 194-198

[28] ZhangY, JonesM, McCabeA, et al.. MyD88 signaling in CD4 T cells promotes IFN-gamma production and hematopoietic progenitor cell expansion in response to intracellular bacterial infection. J Immunol, 2013, 190(9): 4725-4735

[29] WuZ, XingM, WeiS, et al.. Establishment of a Predictive Model Related to Pathogen Invasion for Infectious Diseases and Its Diagnostic Value in Fever of Unknown Origin. Curr Med Sci, 2018, 38(6): 1025-1031

[30] GongF, ZhanW, WangL, et al.. Role of MexA-MexB-OprM efflux pump system in chronic Pseudomonas aeruginosa pulmonary infection in mice. J Huazhong Univ Sci Technolog [Med Sci], 2012, 32(4): 546-551

[31] BryanCS, AhujaD. Fever of unknown origin: is there a role for empiric therapy?. Infect Dis Clin North Am, 2007, 21(4): 1213-1220

[32] DaiJ, YangL, WangJ, et al.. Prognostic Value of FOXM1 in Patients with Malignant Solid Tumor: A Meta-Analysis and System Review. Dis Markers, 2015, 2015: 352478

[33] HaoX, WangJ, ZhangY, et al.. Clinical characteristics in four pediatric patients with mild encephalitis/encephalopathy with a reversible splenial lesion of corpus callosum. Chin J Neurol, 2015, 48(11): 987-990